focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLIN.L Share News (CLIN)

  • There is currently no data for CLIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Rockhopper rises as Navitas enters project

Wed, 08th Dec 2021 11:45

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

----------

AIM - WINNERS

----------

Rockhopper Exploration PLC, up 22% at 6.38 pence, 12-month range 4.50p-12.50p. The oil & gas exploration and production company says Navitas Petroleum LP is to enter its Sea Lion oil project in the Falkland Islands. Navitas replaces Harbour Energy PLC as Rockhopper's partner in the project.

----------

Equals Group PLC, up 12% at 70.40p, 12-month range 26.10p-73.00. The fintech payments firm says it has "significantly exceeded" its full-year expectations for both adjusted earnings and revenue. Group revenue for the year to date is GBP40.4 million, up 51% from GBP26.8 million for the same period in 2020. The strong revenue performance means increased gross profit and earnings, and Equals says it has exceeded its own full-year profitability forecasts, but does not provide a figure.

----------

Clinigen Group PLC, up 10% at 901.00p, 12-month range 541.50p-912.00p. Shares hit 12-month high after the pharmaceuticals and services provider agrees to be taken private by European investment firm Triton Funds in a GBP1.2 billion deal. Under the terms, Clinigen shareholders will receive 883p a share in cash. This is a 41% premium to the ex-dividend closing share price on December 1, which was the last business day before takeover talks were first announced. Clinigen shareholders will also be entitled to receive the previously declared final dividend of 5.46p a share.

----------

AIM - LOSERS

----------

Byotrol PLC, down 16% at 4.22p, 12-month range 4.00p-7.70p. Shares in the antimicrobial technologies company hit fresh 12-month low after profit warning and says its first half performance was below expectations. For six months to September 30, swings to pretax loss of GBP141,000 from GBP1.0 million profit year before. "Whilst we expect to be both profitable and cash generative in the second half of the year, with these uncertainties it is difficult to predict the quantum at this juncture. At present we are expecting IP sales to offset the majority of the anticipated shortfall in profit on product sale, but projecting the timing of IP sales is even more uncertain, so we feel it prudent to now reduce market guidance for the current financial year," it says.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
13 Feb 2019 10:43

WINNERS & LOSERS SUMMARY: Tullow Oil Up 6% After Reinstating Dividend

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.----------FTSE 100 - WINNERS----------Smurfit

Read more
13 Feb 2019 10:05

Clinigen bounds upwards on purchase of Proleukin's US rights

(Sharecast News) - Clinigen Group shares jumped on Wednesday after the company signed an agreement with Novartis to acquire the US rights to its Proleukin drug for up to $210m in cash.

Read more
13 Feb 2019 08:42

Clinigen Stock Climbs As It Buys Proleukin's US Rights From Novartis

LONDON (Alliance News) - Pharmaceuticals firm Clinigen Group PLC's shares rose early Wednesday as it announced the purchase of the rights to one of Novartis International AG's were up 12%

Read more
5 Feb 2019 10:49

Clinigen Group Appoints Accountant Nick Keher Chief Financial Officer

LONDON (Alliance News) - Clinigen Group PLC on Tuesday said it appointed Nick Keher as group chief financial officer with effect from March 19.Keher replaces current CFO Martin Abell, who a

Read more
5 Feb 2019 07:56

Clinigen appoints Nick Keher as new CFO

(Sharecast News) - AIM-listed pharmaceutical and services company Clinigen Group has appointed Nick Keher as its new chief financial officer with effect from 19 March.

Read more
15 Jan 2019 09:37

Clinigen Outlook Confident As Revenue And Profit Grow In First Half

LONDON (Alliance News) - Clinigen Group PLC on Tuesday expressed confidence in delivering progress in its full financial year after it saw a strong earnings growth in the first half.The for

Read more
15 Jan 2019 09:22

Acquisitions spur Clinigen to profit and revenue growth

(Sharecast News) - Clinigen Group on Tuesday reported that, following a series of acquisitions, it expects to report a sharp rise in revenue and profit when it publishes its half-year results next month.

Read more
1 Nov 2018 16:03

UK Shareholder Meetings Calendar - Next 7 Days

Friday 2 NovemberMurgitroyd GroupMonday 5 NovemberRandgold Resources (re Barrick Gold

Read more
27 Sep 2018 17:45

UPDATE: Clinigen In Placing For Two New Purchases; Earnings Jump (ALLISS)

LONDON (Alliance News) - Clinigen Group PLC on Thursday said it placed 9.5 million shares at a price of 845 pence each, raising GBP80 million.The stock closed 11% lower on Thursday at per a

Read more
27 Sep 2018 12:14

Thursday broker round-up

(Sharecast News) - Thomas Cook Group: UBS upgrades to neutral with a target price of 60p.

Read more
27 Sep 2018 10:05

Clinigen In Share Placing For Two New Purchases; Annual Earnings Jump (ALLISS)

LONDON (Alliance News) - Clinigen Group PLC on Thursday announced a share placing to help pay for the acquisition of packaging and distribution services company CSM Parent Inc for up to USD240 in

Read more
27 Sep 2018 08:04

Clinigen announces two new acquisition targets following 'another year of good progress'

(Sharecast News) - Clinigen plans to raise £80m from investors to fund two new acquisitions following a "strong performance" from one of its previous additions in its last trading year.

Read more
20 Sep 2018 16:12

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 21 September Smiths GroupFull Year ResultsSIGHalf Year SaatchiHalf Year +

Read more
25 Jul 2018 14:40

Clinigen makes second July drug acquisition

(Sharecast News) - Pharmaceutical and services company Clinigen has acquired the global rights to severe malignant osteoperosis treatment Imukin from Horizon Pharma for an undisclosed sum.

Read more
25 Jul 2018 09:48

Clinigen Acquires Global Rights For Osteoporosis Drug Imukin

LONDON (Alliance News) - Clinigen Group PLC said Wednesday that it acquired the global rights to osteoporosis drug Imukin from Horizon Pharma PLC.The FTSE 250 pharmaceutical company said it

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.